IX

IDEXX Laboratories IncFRA IDEXX Stock Report

Last reporting period 30 Sep, 2024

Updated 11 Nov, 2024

Last price

Market cap $B

41.678

Mega

Exchange

XFRA - Deutsche Boerse AG

IX1.F Stock Analysis

IX

Attractive

Based on Eyestock quantitative analysis, IX1.F`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

109/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

31.3 %

Greatly undervalued

Market cap $B

41.678

Dividend yield

Shares outstanding

82.903 B

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also offers human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment provides products and services for veterinarians and the biomedical research community, primarily related to diagnostics and information management. The Water segment provides testing solutions for the detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry. The Company has sales offices outside the United States in all regions, including Africa, Asia Pacific, Canada, Europe, the Middle East, and Latin America.

View Section: Eyestock Rating